Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis bladder pain syndrome patients Journal of Translational Medicine Springer Nature Link BPC 157 and the Difference Between an Evidence Gap and a Cover Up: What the entire human evidence base actually looks like, and the questions to ask next. WellFounded Founders Health & Current updates relating to treatment for interstitial cystitis bladder pain syndrome: systematic review and network meta analysis BMC Urology Springer Nature Link Effect of BPC 157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts The Model of Interstitial Cystitis for Evaluating New Molecular Strategies of Interstitial Regeneration in Humans